MGMT and glioblastoma: Our results provide novel mechanisms for understanding the methylation in the GBM and identify some biomarkers for prognosis of two different GBM types of MGMT promoter unmethylated or methylated GBM, and reveal the fundamental differences between those groups; this paper also emphasizes the available treatment strategies for GBM.